| Dr Michael Johnson, MD, FACS | |
|
2707 Medical Office Pl, Goldsboro, NC 27534-9458 | |
| (919) 735-9146 | |
| (919) 735-0582 |
| Full Name | Dr Michael Johnson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 36 Years |
| Location | 2707 Medical Office Pl, Goldsboro, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083690572 | NPI | - | NPPES |
| 46388 | Other | NC | BCBSNC |
| 8946388 | Medicaid | NC | |
| 040009804 | Other | NC | RETIRED RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 36746 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wayne Memorial Hospital | Goldsboro, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unc Physicians Network | 5496940546 | 709 |
News Archive
The American Gastroenterological Association Research Foundation is pleased to announce the 2014 AGA Research Scholars. The AGA Research Scholar Awards program, launched in 1984, enables young investigators to develop independent and productive research careers in digestive diseases. This year, the AGA Research Scholar Awards fund an additional year allowing for three consecutive years of funding.
Having established that excessive fat tissue can fuel the growth of certain cancers, researchers have turned their attention to the molecular mechanisms involved in the process in the hopes of developing new cancer treatments.
Ontario is investing $25 million over five years to support new treatments and therapies for people living with chronic diseases, such as cancer, multiple sclerosis and diabetes.
People who feel secure in in their relationship with their partner have a more satisfactory sex life and are more able to be sensitive in the affection they give. However, people who are insecure, who tend towards anxiety or avoidance and are compulsive or controlling in their affection experience more conflict in their sexual desire and are less happy in their relationships, according to a study by the University of the Basque Country.
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
› Verified 6 days ago
| Entity Name | Unc Physicians Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750704367 PECOS PAC ID: 5496940546 Enrollment ID: O20101115000646 |
News Archive
The American Gastroenterological Association Research Foundation is pleased to announce the 2014 AGA Research Scholars. The AGA Research Scholar Awards program, launched in 1984, enables young investigators to develop independent and productive research careers in digestive diseases. This year, the AGA Research Scholar Awards fund an additional year allowing for three consecutive years of funding.
Having established that excessive fat tissue can fuel the growth of certain cancers, researchers have turned their attention to the molecular mechanisms involved in the process in the hopes of developing new cancer treatments.
Ontario is investing $25 million over five years to support new treatments and therapies for people living with chronic diseases, such as cancer, multiple sclerosis and diabetes.
People who feel secure in in their relationship with their partner have a more satisfactory sex life and are more able to be sensitive in the affection they give. However, people who are insecure, who tend towards anxiety or avoidance and are compulsive or controlling in their affection experience more conflict in their sexual desire and are less happy in their relationships, according to a study by the University of the Basque Country.
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Johnson, MD, FACS 2000 Perimeter Park Dr Ste 200, Morrisville, NC 27560-8442 Ph: () - | Dr Michael Johnson, MD, FACS 2707 Medical Office Pl, Goldsboro, NC 27534-9458 Ph: (919) 735-9146 |
News Archive
The American Gastroenterological Association Research Foundation is pleased to announce the 2014 AGA Research Scholars. The AGA Research Scholar Awards program, launched in 1984, enables young investigators to develop independent and productive research careers in digestive diseases. This year, the AGA Research Scholar Awards fund an additional year allowing for three consecutive years of funding.
Having established that excessive fat tissue can fuel the growth of certain cancers, researchers have turned their attention to the molecular mechanisms involved in the process in the hopes of developing new cancer treatments.
Ontario is investing $25 million over five years to support new treatments and therapies for people living with chronic diseases, such as cancer, multiple sclerosis and diabetes.
People who feel secure in in their relationship with their partner have a more satisfactory sex life and are more able to be sensitive in the affection they give. However, people who are insecure, who tend towards anxiety or avoidance and are compulsive or controlling in their affection experience more conflict in their sexual desire and are less happy in their relationships, according to a study by the University of the Basque Country.
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
› Verified 6 days ago
Mrs. Marilyn G Wallace, LPN Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2707 Medical Office Pl, Goldsboro, NC 27534 Phone: 919-735-9146 Fax: 919-735-0582 | |
Dr. Daniel Whitley Jr., M.D., F.A.C.S. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2707 Medical Office Pl, Goldsboro, NC 27534 Phone: 919-735-9146 Fax: 919-735-0582 | |
Ms. Fawn Serene Callie, PA-C Otolaryngology Medicare: Medicare Enrolled Practice Location: 2707 Medical Office Pl, Goldsboro, NC 27534 Phone: 919-735-9146 Fax: 919-735-0582 | |
Collin Daniel Smith, DO Otolaryngology Medicare: Medicare Enrolled Practice Location: 2707 Medical Office Pl, Goldsboro, NC 27534 Phone: 740-407-1040 Fax: 919-735-0582 | |
Samuel P Davis Iii, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2707 Medical Office Pl, Goldsboro, NC 27534 Phone: 919-735-9146 Fax: 919-735-0582 |